Category: diagnostic

HPV panel streamlines assay qualification

THE NEW HPV Genotype Qualification Panel from Seracare has been launched in response to rising demand for HPV (human papillomavirus) assay qualification. “Increased awareness of the risks of human papillomavirus (HPV) has generated a need for accurate testing,” said Chris…

Research projects target sepsis

SEPSIS is the target of the latest development in the UK’s Detection and Identification of Infectious Agents (DIIA) programme, which manages a number of government-backed projects to develop technologies to reduce the impact of infectious agent. Sepsis is the result…

Vitamin D diluent contains no equine or synthetic plasma

THE LATEST offering in SeraCare Life Sciences’s range, SeraCon Vitamin D Depleted Diluent is a human plasma-based matrix for the development of vitamin D assays. The product is derived entirely from human plasma, with no equine or synthetic plasma, which…

Bringing DNA diagnostics to the point of care

A NEW programme to bring a novel microfluidic DNA-based testing and diagnostics technology to point-of-care settings has been launched by a consortium of LingVitae, Plarion, and KTH Royal Institute of Technology. The technology, called Discipher, exploits ‘centrifugal microfluidics’. Based on…

Microarrrays target key cancer predictors

THE FIRST in a new line of cancer research microarrays from Oxford Gene Technology (OGT) promises confident detection of copy number variation (CNV) and loss of heterozygosity (LOH) on a single chip. The CytoSure Haematological Cancer +SNP array is used…

Towards a future of personalised medicine

SPECIAL REPORT: LabHomepage attended the 9th Planet xMap conference and symposium, held at the Hofburg Palace in Vienna, Austria. With nearly 500 delegates and almost 40 papers presented in 12 sessions over two days, Planet xMap is a significant scientific…

Laboratories go live at Analytica 2012

A NEW development at Analytica 2012 will be the creation of ‘genuine’ laboratory spaces within the exhibition halls. Daily experiment presentations will be held in which exhibiting companies will be able to demonstrate their equipment and instruments. The Live Labs…

First commercially-available parvovirus panel

SERACARE Life Sciences has launched five new infectious disease panels, including the first for parvovirus B19 which is associated with fifth disease. The other new products include panels for human immunodeficiency virus (HIV), hepatitus A (HAV), hepatitus B (HBV), and cytomegalovirus…

IBM enters microfluidic chip market

A MICROFLUIDIC chip aimed at pathology laboratories promises to ease the tedium of tissue staining by allowing the use of multiple stains on a single biopsy sample. Developed by IBM, better known of course as a microelectronics and computer specialist,…